Toshinobu Hayashi

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter].

Zero Events, Limited Precision, and the Interpretation of Olanzapine Safety in Patients with Diabetes Receiving Cisplatin [Response to Letter].

Journal: Drug design, development and therapy

Published: July 30, 2026

Safety of Short-T erm Low-Dose Olanzapine in Patients with Cancer and Diabetes Receiving Cisplatin-Based Chemotherapy: A Retrospective TriNetX Cohort Study.

Safety of Short-T erm Low-Dose Olanzapine in Patients with Cancer and Diabetes Receiving Cisplatin-Based Chemotherapy: A Retrospective TriNetX Cohort Study.

Journal: Drug design, development and therapy

Published: April 10, 2026

Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: a prospective observational study (LODEC-N).

Fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in oxaliplatin-based regimens: a prospective observational study (LODEC-N).

Journal: Cancer chemotherapy and pharmacology

Published: March 17, 2026

Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer.

Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer.

Journal: Anticancer research

Published: March 15, 2026

Clinical outcomes of daptomycin in patients with augmented renal clearance: a case series.

Clinical outcomes of daptomycin in patients with augmented renal clearance: a case series.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: March 13, 2026

Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study.

Effectiveness of continuous pharmacist intervention at maintaining dose intensity in postoperative adjuvant S-1 chemotherapy for gastric cancer: a multicentre retrospective study.

Journal: International journal of clinical pharmacy

Published: March 12, 2026

Comparative efficacy of carbapenem and non-carbapenem empirical therapy for Klebsiella pneumoniae Bacteremia.

Comparative efficacy of carbapenem and non-carbapenem empirical therapy for Klebsiella pneumoniae Bacteremia.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: January 29, 2026

Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.

Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.

Journal: International journal of clinical oncology

Published: January 09, 2026

Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network.

Comparative effectiveness of two first-line, ICI-based regimens for advanced HCC: a target trial emulation using an electronic medical record network.

Journal: Frontiers in oncology

Published: December 26, 2025

Patient Education to Prevent Exposure to Anticancer Drugs among Patients and Caregivers during Outpatient Chemotherapy in Japan: A Cross-Sectional Survey.

Patient Education to Prevent Exposure to Anticancer Drugs among Patients and Caregivers during Outpatient Chemotherapy in Japan: A Cross-Sectional Survey.

Journal: Biological & pharmaceutical bulletin

Published: December 24, 2025

Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Study.

Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Study.

Journal: Cancer management and research

Published: November 28, 2025

Multiple-day dexamethasone for controlling delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy.

Multiple-day dexamethasone for controlling delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy.

Journal: BMC cancer

Published: October 17, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026